Advanced search
Instruments
Name | Stock exchange | Average volume | Price | Type | ||
---|---|---|---|---|---|---|
LYNCH GROUP HOLDINGS LIMITED | LGL | Australian S.E. | 77,032 | 1.38 AUD | Stock | |
MERRILL LYNCH DEPOSITOR INC. 6.0518% INDEX PLUS TRUST SERIES 2003-1 | IPB | Nyse | 1,537 | 25.45 USD | Stock | |
ETC - MERRILL LYNCH AFRICA LIONS INDEX | CPLCI | Swiss Exchange | - | 501 CHF | Certificat | |
ENDLOS INDEXZERTIFIKAT - LUS WIKIFOLIO-INDEX DOPPEL-MOMENTUM NACH LYNCH | Börse Stuttgart | - | 144.5 EUR | Certificat | ||
ENDLOS INDEXZERTIFIKAT - LUS WIKIFOLIO-INDEX CANSLIM MEETS LYNCH | Börse Stuttgart | - | 139.4 EUR | Certificat | ||
ENDLOS INDEXZERTIFIKAT - LUS WIKIFOLIO-INDEX DOPPEL-MOMENTUM NACH LYNCH | LS9QVU | Berne S.E. | - | - CHF | Certificat | |
OPEN END PERLES - MERRILL LYNCH AFRICA LIONS INDEX | Swiss Exchange | - | 1,109 CHF | Certificat | ||
MERRILL LYNCH S.A. IL TRIGGER RED NTS 27/03/37 | 87KO | London S.E. | - | - % | Bond | |
ETC EXCHANGE TRADED COMMODITY - MERRILL LYNCH AFRICA LIONS INDEX | B4NX | Frankfurt | - | - EUR | Certificat | |
ENDLOS INDEXZERTIFIKAT - LUS WIKIFOLIO-INDEX STOCK PICKING NACH PETER LYNCH | Börse Stuttgart | - | 189.6 EUR | Certificat |
News (2785)
Companies (3)
International Star, Inc. operates, through its wholly owned subsidiary, Budding Equity Inc., a royalty-based business that owns intellectual property contracts with movie studios, which provide for the licensing of that intellectual property (IP) to third ...
Lynch Group Holdings Limited is an Australia-based company, which is engaged in the horticultural production and wholesale of flowers and plants. The Company is a wholesaler and grower of flowers and potted plants. Its segments include Australia and China ...
Tapinator, Inc. develops and publishes games for mobile platforms. The Companyâs portfolio includes over 300 titles that have over 500 million mobile downloads, including games such as Video Poker Classic and Crypto Trillionaire. It publishes two types ...
Insiders
Kevin R.
Lynch founded SphynKx Therapeutics LLC in 2010, where he is working as Chief Scientific Officer from 2010.
Dr. Lynch also founded Catena Pharmaceuticals, Inc., where he worked as Vice President-Biological Sciences from 2010 to 2013.
Dr. Lynch also currently works at The University of Virginia School of Medicine, as Vice Chairman and the University of Virginia, as Professor-Pharmacology & Biochemistry from 2012.
Dr. Lynch received his doctorate degree in 1980 from the University of Rhode Island.
No results for this search
- Stock Market
- Advanced search
- Kevin Lynch